JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

Home・Akciju saraksts・AngioDynamics Inc

AngioDynamics Inc

Slēgts

SektorsVeselības aprūpe

10.57 1.83

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

10.27

Max

10.85

Galvenie mērījumi
By Trading Economics
Ienākumi	4.6M -6.4M
Pārdošana	3.7M 79M
Peļņas marža	-7.994
Darbinieki	675
EBITDA	4.4M -436K

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+85.51% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 1. apr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-119M 426M
Iepriekšējā atvēršanas cena	8.74
Iepriekšējā slēgšanas cena	10.57

Ziņu noskaņojums

By Acuity

60%

40%

296 / 352 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

9 / 9.3 Atbalsts un pretestība

AngioDynamics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 3. febr. 23:11 UTC

Galvenie tirgus virzītāji

Iegādes, apvienošanās, pārņemšana

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

2026. g. 3. febr. 23:50 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 3. febr. 23:50 UTC

Tirgus saruna

Nikkei May Decline After Hitting All-Time High -- Market Talk

2026. g. 3. febr. 23:42 UTC

Tirgus saruna

Gold Edges Lower on Possible Technical Correction -- Market Talk

2026. g. 3. febr. 23:41 UTC

Iegādes, apvienošanās, pārņemšana

KKR Makes AI Play With $10.9B Asia Data-Center Deal

2026. g. 3. febr. 23:38 UTC

Peļņas

AMD Sales Climb on Help From Data-Center Business -- Update

2026. g. 3. febr. 23:29 UTC

Iegādes, apvienošanās, pārņemšana

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

2026. g. 3. febr. 23:27 UTC

Iegādes, apvienošanās, pārņemšana

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

2026. g. 3. febr. 23:25 UTC

Iegādes, apvienošanās, pārņemšana

KKR-Consortium Expects Deal to Close by Early 2H of 2026

2026. g. 3. febr. 23:23 UTC

Iegādes, apvienošanās, pārņemšana

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

2026. g. 3. febr. 23:22 UTC

Iegādes, apvienošanās, pārņemšana

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

2026. g. 3. febr. 23:19 UTC

Tirgus saruna

Australia Gold Miners Tipped to Rally Higher -- Market Talk

2026. g. 3. febr. 23:19 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 3. febr. 22:56 UTC

Galvenie tirgus virzītāji

Iegādes, apvienošanās, pārņemšana

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

2026. g. 3. febr. 22:40 UTC

Peļņas

Amdocs Extends Collaboration With T-Mobile

2026. g. 3. febr. 22:39 UTC

Peļņas

Amdocs 1Q Adj EPS $1.81

2026. g. 3. febr. 22:39 UTC

Peļņas

Amdocs 1Q Rev $1.16B

2026. g. 3. febr. 22:39 UTC

Peļņas

Amdocs 1Q EPS $1.45 >

2026. g. 3. febr. 22:38 UTC

Peļņas

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

2026. g. 3. febr. 22:30 UTC

Iegādes, apvienošanās, pārņemšana

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

2026. g. 3. febr. 22:22 UTC

Iegādes, apvienošanās, pārņemšana

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

2026. g. 3. febr. 22:14 UTC

Peļņas

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

2026. g. 3. febr. 22:13 UTC

Peļņas

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

2026. g. 3. febr. 22:12 UTC

Peļņas

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

2026. g. 3. febr. 22:10 UTC

Peļņas

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

2026. g. 3. febr. 22:10 UTC

Peļņas

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

2026. g. 3. febr. 22:10 UTC

Tirgus saruna

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

2026. g. 3. febr. 22:10 UTC

Peļņas

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

2026. g. 3. febr. 22:09 UTC

Peļņas

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

2026. g. 3. febr. 22:09 UTC

Peļņas

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Salīdzinājums

Cenas izmaiņa

AngioDynamics Inc Prognoze

Cenas mērķis

By TipRanks

85.51% augšup

Prognoze 12 mēnešiem

Vidējais 19.33 USD 85.51%

Augstākais 24 USD

Zemākais 16 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi AngioDynamics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

3 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam AngioDynamics Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

9 / 9.3Atbalsts un pretestība

Bearish events outweigh bullish events.

All events are bearish.

There is one bullish event.

Noskaņojums

By Acuity

296 / 352 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.